Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

SillaJen to acquire Jennerex

Nov. 29, 2013

Genmab reaches milestone in Janssen Biotech collaboration

Nov. 27, 2013

Lytix Biopharma enrolls first patient in study of LTX-315

Nov. 27, 2013

E39 is well tolerated in patients with endometrial and ovarian cancer

Nov. 27, 2013

F-star generates an Fcab antibody against HER2

Nov. 21, 2013

Innate Pharma initiates program to develop anti-MICA antibody

Nov. 21, 2013

European approval for Kadcyla

Nov. 20, 2013

Generex Biotechnology reaches prespecified point in phase II trial of breast cancer vaccine

Nov. 19, 2013

First patient treated in study of DNX-2401 and temozolomide for recurrent glioblastoma

Nov. 15, 2013

Roche and immatics biotechnologies sign cancer vaccine collaboration

Nov. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...